Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma

SIMPLE SUMMARY: The possible mechanisms of resistance to atezolizumab/bevacizumab for unresectable HCC and the subsequent response to these therapies remain underexplored. The sequential changes in serum growth factors, including VEGF-A, VEGF-C, VEGF-D, ANG-2, FGF-19, HGF, and EGF during atezolizuma...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zijian, Suda, Goki, Maehara, Osamu, Ohara, Masatsugu, Yoda, Tomoka, Sasaki, Takashi, Kohya, Risako, Yoshida, Sonoe, Hosoda, Shunichi, Tokuchi, Yoshimasa, Kitagataya, Takashi, Suzuki, Kazuharu, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Ogawa, Koji, Ohnishi, Shunsuke, Sakamoto, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913372/
https://www.ncbi.nlm.nih.gov/pubmed/36765554
http://dx.doi.org/10.3390/cancers15030593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913372/
https://www.ncbi.nlm.nih.gov/pubmed/36765554
http://dx.doi.org/10.3390/cancers15030593

Ejemplares similares